OraQuick HIV 25 Count rapid antigen Positive controls

Positive controls

7% Flu B Sensitivity 87

all while promoting healthy weight control and aiding in blood pressure modulation

and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly from anterior nasal swab specimens of individuals with signs and symptoms of respiratory infection consistent with COVID-19 within the first five (5) days of symptom onset when tested at least twice over three days with at least 48 hours between tests

Dipstick Easy to use

OraQuick HIV 25 Count rapid antigen Positive controlsThe OraQuick Advance Rapid HIV 1 2 Antibody Test is a simple solution that enables healthcare providers to deliver an accurate diagnosis to HIV 1 2 patients in as little as 20 minutes. Clia waived and FDA approved for oral fluid, fingerstick and venipuncture whole blood and offers the ability to rest in non traditional testing environments, such as outreach programs and mobile testing clinics. Walk away procedure allows providers to batch tests,